Prescription Drug Procurement and the Federal Budget
This brief commissioned by the Foundation considers areas where Medicare faces limited opportunity for market-based competition and price negotiation to drive down drug spending.
View the Latest: Prescription Drugs
Filter
-
-
Pharmaceutical Policy and Pricing: Are Other Countries Getting Greater Value?
Event Date:EventSpending on prescription drugs in the U.S. rose at a faster clip in 2009 than spending for hospital and physician care, a trend that is expected to continue through 2020. The desire to get a handle on drug spending is a focus not only in the U.S. but in other countries as well.
-
Medicare Part D Data Spotlight: A First Look at Part D Plan Offerings in 2012
ReportThis data spotlight examines the stand-alone Part D drug plan options available to Medicare beneficiaries in 2012. Medicare beneficiaries will, on average, be able to choose from 31 stand-alone Medicare Part D prescription drug plans to choose from, a new Kaiser analysis finds.
-
Medicare Part D 2011 Data Spotlights
ReportThe Kaiser Family Foundation has issued a collection of analyses related to the Medicare Part D stand-alone drug plan options available to seniors for calendar year 2011. These spotlights focuses on key aspects of the drug plan choices available and relevant trends since the Medicare drug benefit took effect in 2006.
-
Analysis of Medicare Prescription Drug Plans in 2011 and Key Trends Since 2006
ReportThis report presents findings from an analysis of the Medicare Part D marketplace in 2011 and changes in drug coverage and costs since 2006.
-
Medicare Part D 2011 Data Spotlight: The Coverage Gap
ReportThis data spotlight examines the availability of gap coverage in the private Medicare Part D drug plans offered to beneficiaries in 2011, the first year of the phase-out of the gap, as required under the 2010 health reform law.
-
The Role of Clinical and Cost Information in Medicaid Pharmacy Benefit Decisions: Experience in Seven States
Issue BriefThis policy brief provides perspective on the potential for using comparative effectiveness research in Medicaid pharmacy programs by looking at seven states to determine how they currently evaluate relative clinical and cost information about prescription drugs when making coverage decisions for their Medicaid pharmacy benefits.
-
Medicaid Payment for Outpatient Prescription Drugs
Fact SheetThis fact sheet summarizes Medicaid’s role as the major source of outpatient pharmacy services for low-income Americans. Medicaid spent $25.4 billion on prescription drugs in fiscal year 2009, and outpatient prescription drug coverage is an optional benefit that all state Medicaid programs currently provide. Fact Sheet (.
-
Managing Medicaid Pharmacy Benefits: Current Issues and Options
ReportThis report examines reimbursement, benefit management and cost sharing issues in Medicaid pharmacy programs.
-
Understanding The Effects of The Medicare Part D Coverage Gap in 2008 and 2009
ReportThis Kaiser Family Foundation study examines how the coverage gap in Medicare’s drug benefit known as the “doughnut hole” affects Medicare beneficiaries and their prescribing patterns.